Navigation Links
Neural stem cells attack glioblastoma cells
Date:7/6/2010

In their latest research, scientists of the Max Delbrck Center for Molecular Medicine (MDC) Berlin-Buch, Germany, have demonstrated how the brain's own stem cells and precursor cells control the growth of glioblastomas. Of all brain tumors, glioblastomas are among the most common and most aggressive. Dr. Sridhar Reddy Chirasani, Professor Helmut Kettenmann and Dr. Rainer Glass (all MDC) and Dr. Michael Synowitz (Charit Universittsmedizin Berlin) have now shown in cell culture and mouse model experiments just how the body's own protective mechanism they identified in an earlier study, actually works (Brain, July 6, 2010, doi:10.1093/brain/awq128)*.

Glioblastomas are brain tumors that are most common in adults in their mid-fifties or early sixties. The causes for developing the disease are not yet known. Researchers assume that misdirected neural stem cells / precursor cells mutate into cancer cells and can form glioblastomas.

Several years ago the MDC and Charit researchers were able to show that normal stem cell/ precursor cells of the brain attack the tumor. Apparently, the tumor itself entices these stem cells to migrate over relatively long distances from the stem cell niches of the brain. Why this is so is unclear. Moreover, the researchers still do not know which substance attract the stem cells to the tumor. However, now they have discovered how the stem cells keep the tumor in check.

Stem cell protein induces signaling in glioblastoma cells

The scientists showed that the neural stem cells and neural precursor cells release a protein that belongs to the family of the BMP proteins (bone morphogenetic protein). This protein received its name for its ability to induce bone and cartilage tissue formation, the first characteristic that was known about it. However, BMP is active in the entire organism even in the brain.

Neural stem cells release BMP-7 in the brain in the vicinity of the glioblastoma cells. The protein influences a small population of cancer cells, the so-called tumor stem cells. The current consensus of researchers is that these tumor stem cells are the actual cause for the continuous tumor self-renewal in the brain. A small quantity of these cells is sufficient to form new tumors again even after surgery. BMP-7 induces signaling in the tumor stem cells, causing them to differentiate. This means that they are no longer tumor stem cells.

However, the activity of stem cells in the brain and thus of the body's own protective mechanism against glioblastomas diminishes with increasing age. This could explain why the tumors usually develop in older adults and not in children and young people.

Aim the destruction of tumor stem cells

The discovery of the tumor stem cells has led to new concepts in the therapy of glioblastomas. "Normal cancer cells" can be destroyed using conventional therapies (surgery, radiation, chemotherapy), which are seldom successful in tumor stem cells. The aim is therefore to develop therapy concepts to destroy these tumor stem cells. The findings from the mouse experiments of the researchers in Berlin could point to a new approach: reprogramming tumor stem cells into less harmful cells, which could then be destroyed with a therapy.


'/>"/>

Contact: Barbara Bachtler
bachtler@mdc-berlin.de
49-309-406-3896
Helmholtz Association of German Research Centres
Source:Eurekalert

Related biology news :

1. Searching for causes of neural disconnection in schizophrenia
2. Neural tissue contains imbalanced levels of proteins, U-M study finds
3. Induced neural stem cells: Not quite ready for prime time
4. Brain-controlled cursor doubles as a neural workout
5. Case Western Reserve University discovers Merkel cell originates from skin, not the neural crest
6. Mouse brain rewires its neural circuits to recuperate from damaged neural function after stroke
7. Essential nutrient found in eggs may help lower risk of neural tube defects
8. Neural stem cell differentiation factor discovered
9. Identification of a key molecular pathway required for brain neural circuit formation
10. Early brain activity sheds new light on the neural basis of reading
11. Creating ideal neural cells for clinical use
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/12/2017)...  Trovagene, Inc. (NASDAQ: TROV ), a ... that it has signed agreements with seven strategic partners ... Middle East for commercialization of the ... wave of international distribution agreements for Trovagene,s CLIA based ... The initial partners will introduce Trovagene,s liquid biopsy ...
(Date:1/11/2017)... 2017 Intoxalock, a leading ignition interlock provider, ... its patent-pending calibration device. With this new technology, Intoxalock ... upload data logs and process repairs at service center ... "Fighting drunk driving through the application of cutting-edge technologies ... but also for the customer who can get back ...
(Date:1/6/2017)... Colo. , Jan. 5, 2017  SomaLogic ... the "Digital Life Alliance" established by iCarbonX, the ... 2015 to build a "Global Digital Health Ecosystem ... on a combination of individual,s biological, behavioral and ... the agreement between the companies, SomaLogic will provide ...
Breaking Biology News(10 mins):
(Date:1/20/2017)... 20, 2017 Stock-Callers.com explores the ... influenced the most recent performances of select equities. In ... RGLS ), Abeona Therapeutics Inc. (NASDAQ: ... ), and Sage Therapeutics Inc. (NASDAQ: SAGE ... View Research, global Biotech market size is expected to reach $604.40 billion by ...
(Date:1/20/2017)... NEW YORK , January 20, 2017 ... Health Organization, cancer is one of leading causes of ... in 2012. Although the number of cancer related deaths ... since 1990. Rising in incidence rate of various cancers ... According to a research report by Global Market Insights, ...
(Date:1/19/2017)... Research and Markets has announced the addition ... Type, Application - Global Opportunity Analysis and Industry Forecast, 2014-2022" ... ... is projected to reach $15,737 million by 2022 from $6,521 in ... Omic technologies segment accounted for more than half ...
(Date:1/19/2017)... and HOUSTON , Jan. 19, ... today announced the formation of its Medical/Clinical Advisory ... and industry veterans who enhance the range and ... accelerates development of its novel prenatal diagnostic tests.  ... clinical and strategic guidance for the company,s product ...
Breaking Biology Technology: